Attached files
file | filename |
---|---|
10-K - China Yongxin Pharmaceuticals Inc. | v177274_10k.htm |
EX-31.2 - China Yongxin Pharmaceuticals Inc. | v177274_ex31-2.htm |
EX-31.1 - China Yongxin Pharmaceuticals Inc. | v177274_ex31-1.htm |
EX-21.1 - China Yongxin Pharmaceuticals Inc. | v177274_ex21-1.htm |
EX-10.17 - China Yongxin Pharmaceuticals Inc. | v177274_ex10-17.htm |
EX-10.14 - China Yongxin Pharmaceuticals Inc. | v177274_ex10-14.htm |
EX-10.13 - China Yongxin Pharmaceuticals Inc. | v177274_ex10-13.htm |
EX-10.15 - China Yongxin Pharmaceuticals Inc. | v177274_ex10-15.htm |
EX-10.16 - China Yongxin Pharmaceuticals Inc. | v177274_ex10-16.htm |
Exhibit
32.1
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT
TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the report of China Yongxin Pharmaceuticals Inc. (the “Company”)
on Form 10-K for the period ending December 31, 2009, as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), each of
the undersigned, in the capacities and on the dates indicated below, hereby
certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
/s/ Yongxin Liu
|
Yongxin
Liu
Chief
Executive Officer
March
30, 2010
|
/s/ Harry Zhang
|
Harry
Zhang
Chief
Financial Officer
March
30,
2010
|
A signed
original of this written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.